Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
127
×
Tags
national blog main
127
×
startups
127
×
life sciences
national top stories
biotech
deals
vc
boston blog main
san francisco blog main
texas blog main
wisconsin blog main
boston top stories
new york blog main
san diego blog main
texas top stories
software
wisconsin top stories
fda
san francisco top stories
san diego top stories
seattle blog main
medical devices
tech
venture capital
new york top stories
detroit blog main
healthcare
innovation
seattle top stories
clinical trials
detroit top stories
raleigh-durham blog main
investing
boulder/denver blog main
cancer
funding
medical device
national
texas
indiana blog main
What
medical
new
startup
based
million
bio
innovation
roundup
raised
san
tech
health
technology
drug
company
drugs
healthcare
latest
medicines
news
companies
developing
wi
announced
raises
texas
capital
catch
deal
life
software
therapeutics
venture
biotech
digital
let’s
tx
week
antonio
business
Language
unset
unknown
Current search:
" national blog main "
×
photo
×
startups
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
WI Watchlist: Epic, Shine, Venture Investors, Stratatech & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
WI Watchlist: E-Scooters, CUNA Incubator, Curate Funding & More
@xconomy.com
4 years ago
Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company
@xconomy.com
4 years ago
New Funds for Procyrion, Remedy, OncoNano, Vyopta & More TX Tech
@xconomy.com
4 years ago
Healthtech Startups: Connect with HHS Officials in Detroit on July 15
@xconomy.com
4 years ago
WI Watchlist: Microsoft, Exact Sciences, Shine & MKE Tech Hub
@xconomy.com
4 years ago
Providence St. Joseph to Buy Wisconsin Health IT Consultant Bluetree
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
4 years ago
Review: Inside the House of Lies at Theranos
@xconomy.com
4 years ago
Boston Tech Watch: Polaris, GE, DataRobot, Facial Recognition Woes
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com
4 years ago
From Farm to (Financial) Table: Holt Ventures Partner Meg Paulus
@xconomy.com
5 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
@xconomy.com
5 years ago
WI Watchlist: Montage, LÜM, WEDC, Titan Spine, Polco, Swallow & More
@xconomy.com
5 years ago
HAP Partners With Livongo on Tech-Enabled Diabetes Compliance Program
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Seattle’s TransformativeMed Carves Out Niche in Medical Specialties
@xconomy.com
5 years ago
MedCognition Making Augmented Reality Emergency Training for US Army
@xconomy.com
5 years ago
Meet the Xconomy Awards San Diego Digital Trailblazer Finalists
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Roswell, Organovo & More: Xconomy Awards Innovation at the Intersection Finalists
@xconomy.com
5 years ago
NorthStar Secures $75M+ as Medical Radioisotope Competition Revs Up
@xconomy.com
5 years ago
Imbed Biosciences Gets $2M Boost for Silver-Based Wound Dressings
First
Prev
Page 1
(current)
Next
Last